Evaluation of the relationship between weight change and glycemic control after initiation of antidiabetic therapy in patients with type 2 diabetes using electronic medical record data-Reference-Cited by-同舟云学术

Evaluation of the relationship between weight change and glycemic control after initiation of antidiabetic therapy in patients with type 2 diabetes using electronic medical record data

Published:2014-03 Issue:3 Volume:103 Page:402-411
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

McAdam-Marx Carrie,Mukherjee Jayanti,Bellows Brandon K.,Unni Sudhir,Ye Xiangyang,Iloeje Uchenna,Brixner Diana I.

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference32 articles.

1. Diabetes and obesity: therapeutic targeting and risk reduction – a complex interplay;Niswender;Diabetes Obes Metab,2010

2. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control;Rodbard;Endocr Pract.,2009

3. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial;Pi-Sunyer;Diabetes Care,2007

4. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes;Petersen;Diabetes,2005

5. Impact of weight gain on outcomes in type 2 diabetes;Ross;Curr Med Res Opin,2011

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in body weight and cardiovascular risk factors in a Chinese population with type 2 diabetes mellitus: a longitudinal study;Frontiers in Endocrinology;2023-04-12

2. Type 2 diabetics followed up by family physicians: Treatment sequences and changes over time in weight and glycated hemoglobin;Primary Care Diabetes;2022-10

3. N-acetyl-L-cysteine treatment reduces beta-cell oxidative stress and pancreatic stellate cell activity in a high fat diet-induced diabetic mouse model;Frontiers in Endocrinology;2022-08-25

4. Interactions Between Therapeutics for Metabolic Disease, Cardiovascular Risk Factors, and Gut Microbiota;Frontiers in Cellular and Infection Microbiology;2020-10-23

Impact of Weight Change in Adults with Type 2 Diabetes Mellitus: A Literature Review and Critical Analysis

;ClinicoEconomics and Outcomes Research;2020-09